ICCM Stock Analysis: Buy, Sell, or Hold?
ICCM - IceCure Medical Ltd. Ordinary Shares
$3.65
-0.24 (-6.17%)
▼
5d:
-31.9%
30d:
+29.89%
90d:
+973.53%
WAIT
LOW Confidence
Analysis Updated: Jul 10, 2026 12:00 AM ET
Earnings: Aug 12, 2026
29d
Get Alerted When ICCM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called ICCM this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: ICCM is down 31.9% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: ICCM is down 31.9% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: ICCM is currently trading at $3.65, which is considered fair relative to its 30-day fair value range of $1.45 to $6.28. From a valuation perspective, the stock is trading at a discount (Forward PE: -0.9) compared to its historical average (7.5). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, ICCM is in a downtrend. Immediate support is located at $0.12, while resistance sits at $5.69. Short-term momentum is weak, with the stock down 6.2% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $30.50 (+735.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ICCM is in a downtrend. Immediate support is located at $0.12, while resistance sits at $5.69. Short-term momentum is weak, with the stock down 6.2% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $30.50 (+735.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$1.45 -
$6.28
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
72.4%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-6.2%)
- BULLISH: Trading 735.6% below Wall St target ($30.50)
- BULLISH: Market expects only 0% annual growth - appears undervalued
- WARNING: Recommendation downgraded due to -31.9% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$1.45 -
$6.28
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$0.13
Resistance Level
$5.69
Current Trend
Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.94
Wall Street Target
$30.50
(+735.6%)
Revenue Growth (YoY)
25.7%
PE vs Historical
-0.9 vs 7.5
CHEAP
Share & Embed Analysis
Last updated: July 13, 2026 4:14 AM ET
Data refreshes hourly during market hours. Next update: 5:14 AM
Data refreshes hourly during market hours. Next update: 5:14 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ICCM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$74 | 65 BUY |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$386 | 63 BUY |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$116 | 63 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$97 | 66 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$239 | 58 HOLD |
